Medicare’s Low Uptake of New Alzheimer’s Drugs Leaves Spending Forecasts Unchanged
Medicare’s spending projections for new Alzheimer’s drugs Leqembi and Kisunla have been slashed due to minimal uptake, with no significant spending ex...
Medicare’s spending projections for new Alzheimer’s drugs Leqembi and Kisunla have been slashed due to minimal uptake, with no significant spending ex...
KFF Health News experts Céline Gounder and Renuka Rayasam addressed critical health issues on national broadcasts. Gounder highlighted FDA baby formul...
A surge in demand for estrogen patches has created a supply shortage that could persist for up to three years. The FDA's removal of black box warnings...